A reliable, robust assay system which can be deployed to a point of care is useful in a number of settings. For example, where there is an infectious disease outbreak in a remote area (e.g., the recent Ebola outbreaks), such an assay is of benefit for arresting the outbreak as quickly as possible (infected individuals can be quickly identified and then given medical care) and for keeping health care providers safer.
An assay driver system can be used to automate an assay. One type of assay driver induces movement of magnetic beads which contact sample (or control) and then carry it into contact with assay reagents. The movement has to be carefully timed, to ensure proper reaction times for different reagents. The results must also be readable for fast interpretation. One type of point of care assay system suitable for use with an assay driver herein is disclosed in US Publ'n No. 2016/0195523 (incorporated by reference). This application discloses a cartridge having wells containing various assay reagents. Magnetic beads also reside in the wells, and the magnetic beads are moved among the wells in order to carry sample into contact with different assay reagents in different wells.
An assay driver system can be used to automate the assay, by moving magnets (and carrying the magnetic beads) through the wells of the cartridge, and into contact with the assay reagents in various wells. The movement has to be carefully timed, to ensure proper reaction times for different reagents. The results must also be read and sent for interpretation, and to permit quick action. No current system automates these functions. Remote authentication of the cartridge (to provide the proper instructions to the driver) and automation of the individual assays which can be performed by the cartridge, coupled with reading and sending of assay results from the point of care is needed, to solve the problems associated with an infectious disease spreading rapidly among a population.
In addition to carefully timing the movement of magnetic beads to ensure proper reaction times between them and different reagents in currently known assay driver systems, during mixing of the beads with the reagents in wells of an assay cartridge, an appropriately sized and directed, and a properly moved magnetic field is required to ensure proper movement of the magnetic beads throughout each well, and proper mixing between magnetic beads and the reagents in each well.
Hence there is a need for an improved automated assay driver system which is more accurate, is more efficient, and facilitates faster interpretation of assay results.
The invention is an apparatus and method for performing an assay where a sample or binding agent or antigen, carried by magnetic beads, is brought in contact with different assay reagents in different wells of an assay cartridge. The movement of magnetic beads among wells of the cartridge is driven and guided by controlled movement of magnets or a magnetic array, preferably including scanning magnets and corresponding orienting magnets. The magnets are preferably permanent magnets, such as rare earth magnets, though other means of generating magnetic force, including electromagnets, could be used. The movement of the magnets is controlled by an apparatus in accordance with a set of authenticated assay instructions.
In one embodiment the apparatus comprises a substantially transparent assay cartridge, a scanning platform for the assay cartridge, and an array of magnets installed in a magnet holder contained in a magnet carrier base. The magnet carrier base is moved by an externally threaded driving rod along two metallic rail rods that lie parallel to the driving rod. The array of magnets preferably further comprises a plurality of spherical scanning magnets which are oriented to align with the poles using a corresponding cylindrical orienting magnet for each scanning magnet. Each orienting magnet stands vertically, with one pole at the top, and aligned below its corresponding scanning magnet. The orienting magnets can be fixed, but the spherical magnets can preferably move in their holder enough such that the poles align the same way as the poles of the orienting magnets. The magnet carrier base resides under the scanning platform.
The assay cartridge preferably includes one or more series of wells, where each series of wells is arranged along a line parallel with the driving rod. In one embodiment, the cartridge has two series of wells, where one series has magnetic beads and control analyte in two of its wells, and assay reagents in others, and where the second series is identical to the first except that the sample is introduced in place of the control analyte. The magnet carrier base containing a magnet holder is positioned a specific distance below the scanning platform (having the assay cartridge placed on it) such that the magnetic beads in the assay cartridge experience a defined magnitude of magnetic field (provided by scanning magnets and orienting magnets). The magnet carrier base is movable with respect to the assay cartridge along a first axis (parallel to the driving rod), and the magnet holder is movable along a second axis, wherein the first axis intersects the second axis. Movement of the magnet carrier base along the first axis is powered by rotation of the externally threaded driving rod which extends through a mating threaded portion of the magnet carrier base; rotation of the externally threaded driving rod is driven by the shaft of a stepping motor which can move a specified increment and hold. Movement of the magnet holder along the second axis is powered by an electromagnet coil, such as a linear solenoid actuator, which moves the magnet holder on activation.
While moving along the first axis, the magnet carrier base preferably slides on two rail rods which extend through the magnet carrier base. The two rail rods prevent skewing of the magnet carrier base while moving along the first axis. Further, the two rail rods may also be in electrical contact with the electromagnet coil which, when actuated by applying an electrical potential difference across the rods, moves the magnet holder along the second axis. A compressible spring provided with the magnet holder causes the magnet holder to return back along the second axis when the coil is de-actuated or when the potential applied to the coil is substantially reduced from the actuating potential.
To automate the movement of the magnet carrier base and magnet holder (and the array of magnets) within a predefined two-dimensional space (in the directions of the first and the second axes), the device is further equipped with a microcomputer, which controls the operations of the stepping motor, and varies the levels of electrical potential difference applied to the coil. The microcomputer is powered by a DC power source included in the device.
To conduct an assay, a loaded assay cartridge (preferably having a sample, control analyte, magnetic beads and reagents loaded in wells) is placed on the scanning platform. Based on a QR or barcode identifier, the cartridge identity is authenticated and a set of assay instructions are sent to the device. The microprocessor drives and guides movement of the magnet carrier base and magnet holder (and the array of magnets) by executing the instructions. The magnetic beads follow movement of the scanning platform, and travel from one well to another to interact with different reagents in performance of the assay.
Embodiments of the invention are discussed in greater detail with reference to the accompanying figures in the detailed description which follows.
It should be understood that the drawings and the associated descriptions below are intended only to illustrate one or more embodiments of the present invention, and not to limit its scope. The drawings are not necessarily to scale.
The term “magnetic beads” refers to bead-shaped objects of any size (including microbeads) and composition which can be attracted or repulsed by a magnetic force, including objects containing paramagnetic materials or magnetizable materials, such as conductors, and including conductive metals.
Reference will now be made in detail to a first embodiment of an assay device of the invention with reference to the accompanying figures. As illustrated in
Driving box cover 102 includes hole 103 where cable 105 with microcomputer connector end 113 extends through. Pivot pin 101 and lock member 99 are shown exploded in
Scanning box 108 includes a main circuit board 117 which has a microcomputer 107, a mating connector 119 (shown in outline) for connector end 113, a bluetooth unit 109 (GSM-HSPA), a QR scanner 121, and QR circuit board 123 allowing reading the codes to identify the loaded assay cartridge assembly 10, when it is placed on scanning platform 106. Scanning box 108 also includes battery pack 9, DC input port 81 (which can be connected with a power source) and on-off switch 83.
As seen in
Referring to the two different embodiments shown in
While the solenoid 132, the solenoid shaft 134, the compressible spring 136, the magnet holder 138, and the magnet carrier base 140 lie in first compartment 110, the coupling cylinder 126, and connector 142, lie in the second compartment 112. The DC stepping motor 122 lies in the third compartment 141.
In another embodiment, instead of ribbon 158 or brushes as in
Referring to
Coupling cylinder 126 couples the metallic driving shaft 124 and the threaded driving rod 125 and keeps them aligned along a common axis 192. A longitudinal bore 127 extends through the coupling cylinder 126. An unthreaded end of the threaded driving rod 125 and of the metallic driving shaft 124 extend into the bore 127 form its opposite ends.
In alternative embodiments, other means to couple the threaded driving shaft 124 with the coupling cylinder 126 may be used. For example, a fully threaded driving shaft 124 and rod 125 could be screwed into either end of the coupling cylinder 126, or welded into the coupling cylinder 126, or mechanically joined with gears and sprockets.
Connector 142 from main circuit board 117 provides connection to the stepping motor 122 through outputs 176, 178, and connection to solenoid 132 through outputs 180 and 188. Wires 152 and 156 are preferably grounded as shown. The main circuit board 117 obtains electrical power from input 81.
Optional external inputs to microcomputer 107 from external memory devices (such as flash memories) are connectable to the microcomputer 107 through ports (such as USB ports, not illustrated), and can be included. Further, wireless inputs (for example, to receive instructions from a remote server) can also be provided for microcomputer 107 through the Bluetooth unit 109. When instructed wirelessly through unit 109, unit 109 can wirelessly transmit data generated by assay driver 100 (such as assay data or scanned images of the assay cartridge 10) to intended destinations, such as to an associated server. Further, unit 109 also facilitates wireless communication with associated external devices (such as servers and wireless handheld devices). See
As a result of the coupling provided at the coupling cylinder 126, when driving shaft 124 is rotated by stepping motor 122, coupling cylinder 126 and threaded driving rod 125 also rotate in the same direction. Longitudinal movement of threaded driving rod 125 along its longitudinal axis 192 is prevented by having the end of driving rod 125 extend through an annular bearing 129 residing in wall 190, such that threaded driving rod 125 is freely rotatable around the longitudinal axis 192. See
The stepping motor 122, shaft 124, threaded driving rod 125 and coupling cylinder 126 may be installed within the driving box 104 such that the axis 192 divides the driving box 104 into substantially symmetrical halves. The ends of the first rail rod 128 and the second rail rod 130 are supported by wall 190. Further, first rail rod 128 and second rail rod 130 lie parallel to axis 192. Driving shaft 124 and threaded driving rod 125 pass through apertures in walls 166 and 164 respectively, which are sized and designed to not hinder rotation of driving shaft 124 or threaded driving rod 125.
In the first compartment 110, first rail rod 128, second rail rod 130 and threaded driving rod 125 pass through magnet carrier base 140. Functionally, when the threaded driving rod 125 is rotated in a first direction, induced by rotation of driving shaft 124 by stepping motor 122 in the first direction, the magnet carrier base 140 (which is screwed with the threaded driving rod 125) slides over rail rods 128 and 130 and moves longitudinally towards second compartment 112. Similarly, when threaded driving rod 125 is rotated by stepping motor 122 in the opposite direction, magnet carrier base 140 slides over rail rods 128 and 130 and moves towards wall 190 (i.e. away from the second compartment 112). Rail rods 128 and 130 prevent magnet carrier base 140 from being skewed or tilted to one side or the other, by the forces exerted by the rotation of threaded driving rod 125 during travel.
Another embodiment 300 of the rail support assembly for a magnet carrier base 320 is shown in
The assay device 100 and all components including microcomputer 107 are preferably powered by through an AC-to-DC converter (not shown), which connects to DC input port 81. The AC-to-DC converter receives AC power supply from domestic AC power source (for example, 110V, 60 Hz AC in the USA) through a power cord and provides a reduced or 12V DC supply at its output ports.
It is noted that though the present embodiment is powered by 12V DC supply, some embodiments of the invention may be powered with different DC voltages based on installed circuitry and components, or by DC batteries. Still further, for those embodiments of the invention which obtain DC supply by conversion of an AC power supply, the electrical circuitry for AC-DC conversion can be tailored in accordance with the type of AC power supply available at the location of usage and the desired magnitude of DC supply. For example, if an embodiment of the invention were to be used in the USA, the electrical circuitry for AC-DC conversion can be tailored in accordance with an available type of AC power supply of 110V-60 Hz, to achieve the desired magnitude of DC supply. For use in India, the electrical circuitry for AC-DC conversion can be tailored in accordance with an available type of AC power supply of 230V-50 Hz, and the desired magnitude of DC supply. Hence, all modifications in the circuitry of the device, or other modifications, to provide a desired level of DC supply from an available parent power source (such as AC power supply or battery/ies) are within the scope of the invention.
Stepping motor 122 is powered by connecting first output port 176 and second output port 178 of circuit board 174 to power supply ports 204 and 206 of stepping motor 122, respectively, using wires 148 and 150, respectively. Circuit board 174 is connected with main circuit board 117 through cord 105. Port 208 connects stepping motor 122 to ground through wire 152, and also connects to wire 156 (which connects port 188 to rail rod 130). The actuation of all ports on circuit board 174: port 176 and 178 which control stepping motor 122 and ports 188 and 180 which control current flow to ribbon 158 (
To drive stepping motor 122, either of ports 176 or 178 are enabled by microcomputer 107, providing power to inputs 204 or 206. Providing power to port 204 (while keeping port 206 disabled), powers stepping motor 122 to rotate driving shaft 124 in a first direction. When power is supplied to port 206 (keeping port 204 disabled), motor 122 is powered to rotate driving shaft 124 in the opposite direction. Any rotation of driving shaft 124 in either direction would also drive threaded driving rod 125 the same way. In the current embodiment, the enabling of either of ports 176 or 178 (and thus, powering of ports 204 or 206) leads to a potential difference of 9V DC with respect to port 208.
As noted, port 180 of the connector 142 is either connected to solenoid 132 through ribbon cord 158 (
Input ports 210 and 212 are connected to ends of an electromagnet coil (not illustrated) included in solenoid 132. In an unenergized state of the electromagnet coil (or when port 180 is kept disabled by microcomputer 107), one end of solenoid shaft 134 lies within the solenoid 132. The other end of solenoid shaft 134 lies exterior to solenoid 132 and is connected to magnet holder 138. The solenoid shaft 134 can made of a ferromagnetic magnetic material (such as iron). A compressible spring 136 surrounds the length of the solenoid shaft 134 lying exterior to the solenoid 132. As illustrated, the compressible spring 136 is placed between solenoid 132 and magnet holder 138. Solenoid shaft 134 is movable longitudinally along its axis (which is perpendicular to axis 192, once solenoid 132 is enabled.
As illustrated in
Microcomputer 107 can vary the voltage at port 180 and thus the amount of attractive force exerted by solenoid 132, to induce varying degrees of electromagnetic force pulling shaft 134 into solenoid 132. On being energized by flow of DC current through its coil by application of potential difference across rods 128 and 130 (
The two-dimensional space covered by magnet holder 138 as it moves along axis 192 and perpendicular axis 216 (the axis of shaft 134) is sufficiently large so that the magnet holder 138 can be moved under the scanning platform 106 over most of the surface of assay cartridge 10 (which rests on scanning platform 106). The dimensions of the driving box 104 and all components included within are chosen suitably to facilitate such two-dimensional movement of magnet holder 138.
Based on the type of assay performed and the type of assay cartridge 10 being scanned, the microcomputer 107 can be programmed/instructed to guide movement of magnet carrier base 140 along axis 192, and periodically, solenoid 132 is actuated to move magnet holder 138 back and forth.
An embodiment of assay cartridge 10 is shown in
In one example of an Enzyme-Linked ImmunoSorbent Assay (ELISA) run with assay driver 100, sample solution is introduced into the well adjacent to well 13 (through hole 19) and a control solution is introduced into the well adjacent to well 12. Magnetic beads coated with antibody against antigens in the control solution (and which may target antigens in the sample, if the sample is positive) are also placed into wells 12 and 13.
In an alternative embodiment, the coated magnetic beads may be placed into the well 14 which is immediately adjacent to well 12 (containing control solution) and also into the well 15 which has hole 19 and which is immediately adjacent to well 13 (containing sample solution). From there, during an initial step in the assay, the magnetic beads are moved back into wells 12 and 13, respectively, to respectively contact sample and control solutions. The magnetic beads are then moved through the adjacent wells 14 and 15, respectively, before being moved to the remaining wells, serially. This added movement step can aid in washing of the magnetic beads after contacting samples and control solution and before contacting reagents for the other steps of the assay. In this embodiment, hole 19 would be located in well 13 instead of well 15.
Reagents for other steps in the assay (e.g., solutions of labeled detection antibodies which target and bind to the antigens; solutions to develop the labels on the detection antibodies into discernable colors) are loaded through mini-holes 16 of other wells 14 and 15. These reagents are placed in wells 14 and 15 in a series such that the requisite assay steps are performed as the magnetic beads are moved from wells 12 and 13 and through the series of wells 14 and 15. In an alternative embodiment, unlabeled detection antibodies mixed with labeled secondary antibodies may be used in place of labeled detection antibodies.
Prior to using cartridge 10 in an assay, the barcode 11 is scanned (can be by the scanner included in the scanning box 108 or can be done manually by the user) and the scanned barcode information is sent to a server/website, which identifies the assay type and provides the instructions about the assay steps and their timing (preferably over the Internet) to microcomputer 107 (preferably through a transceiver). Alternatively, the instructions can be retrieved from the server/website and manually input or electronically fed into microcomputer 107.
Cartridge 10 is inverted and placed on scanning platform 106, with the sealed side, i.e., the layer 22 side, facing down (see
Optionally, solenoid 132 can be alternately actuated and de-energized to move magnet holder 138 back and forth to mix the magnetic beads with the solutions in wells 12, 13, 14, 15, any time mixing of well contents and beads is desired. During the mixing sequence, solenoid 132 may be held in the actuated or de-energized position for a defined period (approximately 1 or 2 seconds) to allow the magnetic beads to re-form a cluster. Rather than spring 136, another type of passive return mechanism, including an elastic band, may be used to return holder 138 to its resting position, before another potential is applied. Another coil could also be used to effect such return.
Stepping motor 122 is next actuated for sufficient time to drive movement of magnet carrier base 140 such that scanning magnets 218 move to a position below the last wells 14, 15 in the series—which each contain a development solution for the label. A well 15 with the development solution should develop color after magnetic beads arrive therein (because it is the control assay), and the well in row 14 with the development solution should develop a variable amount of color depending on the amount of analyte present in the sample. Movement of magnet carrier base 140 may also be actuated again, to carry magnetic beads to a previous well 14, 15 in the series so that the beads do not interfere with the optical reading of the developing solution.
In selecting scanning magnets 218 and orienting magnets 220, and the manner of movement of holder 138, important parameters include:
The next step is scanning of the wells 14 and 15 which show color, to confirm the assay is functioning properly (specific wells 15 show color change), and if there was a positive result (based on whether the specific wells 14 shows color change). A sensor which reads overall light intensity (and/or with color filters) may be used to show the chemiluminescence or color change.
The relative antigen concentration in the sample may also be determined, based on the degree of color change. Preferably, the sensor results or the scanned images are captured through scanners 97 (
The assay cartridge 10 described herein is preferably for use with assay driver 100, which actuates and controls performance of the assay, and reports results, in a secure remotely authorized system, as described herein. After assay completion, images scanned and representing the assay results are transmitted for interpretation or to the assay subject or his/her designees (including distribution to anyone who can receive the material under applicable HIPAA regulations).
A flow chart showing the steps of cartridge identification through assay imaging and transmission is shown in
Cartridge 10 is loaded with antibody-coated magnetic beads and reagents suitable for an ELISA, and sample is added to the well adjacent to well 13, and a control is added to the well adjacent to well 12. The instructions are executed to induce assay driver to move magnet carrier base 140, containing magnet holder 138, such that the antibody-coated beads are moved through channels 18 and to the next well 14, 15, respectively. The antibody coating on the beads binds to reactive antigens in the sample or control which reactive antigens are then carried by the beads.
Oscillating movement of magnet holder 138 in a direction the same, different or transverse to the first axis induces mixing of beads with the contents of the wells in which they reside. The mixing can be carried out in certain wells, or in all wells in the series.
It is preferred that the strength of the magnetic field acting on magnetic beads, the acceleration and deceleration of holder 138, the distance of travel of holder 138, and the delay time between movements of holder 138 are adjusted so that the beads spread out somewhat (like a comet tail) when oscillating holder 138 to mix beads with the well contents. Optimization of the movement parameters of holder 138 to achieve rapid mixing of beads and well contents is therefore preferred.
The next wells 14, 15, in the series are loaded with detection antibodies carrying enzyme, or with unlabeled detection antibodies and secondary antibodies carrying enzyme. Ultimately, beads are moved to final wells 14, 15 containing the substrate for the enzyme carried by the detection or secondary antibodies, which induces a detectable color change. The color change can be accomplished with an enzyme-substrate combination. In such case, the wells where there is to be a color change may contain one of the following: PNPP (p-Nitrophenyl Phosphate), ABTS (2,2′-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt), OPD (o-phenylenediamine dihydrochloride), or TMB (3,3′,5,5′-tetramethylbenzidine)]. One suitable enzyme-substrate combination is horseradish peroxidase (HRP) as the enzyme and TMB as the detection substrate. When using chemiluminescent chemicals and HRP, which is another option, light is generated as well as a color change.
Some wells 14, 15 may optionally serve as wash chambers to separate the magnetic beads from regeants not bound to the beads—although this separation is also achieved by passage of the magnetic bead clusters through the air gaps in channels 18. Oscillating movement of magnet holder 138 in a direction transverse to the first axis induces mixing of beads with the contents of wells which contain wash reagents—when the beads reside in those wells.
In a sandwich-type ELISA, the concentration of analyte in sample or control solution is proportional to the amount of the analyte that gets attached to the antibody-coated magnetic particles, which in turn is proportional to the number of detection antibody molecules that get attached to the analyte. Because the detection or secondary antibodies are attached to HRP, the quantity of detection or secondary antibodies bound to the analyte governs the rate of catalytic conversion of TMB.
After a suitable reaction time (for example, 2-10 minutes) the color intensity can be quantified with a light source and detector, for example. The final wells can have results recorded or be scanned and imaged, and the image or results can be transmitted for remote analysis of the assay results, or to the patient or a designated recipient, as described further below. A suitable scanner for generating the assay well readings is a four-channel photoelectric color sensor, capable of sensing the total light signal and up to three color-filtered signals.
The specific methods and compositions described herein are representative of preferred embodiments and are exemplary and not intended as limitations on the scope of the invention. Other objects, aspects, and embodiments will occur to those skilled in the art upon consideration of this specification, and are encompassed within the spirit of the invention as defined by the scope of the claims. It will be readily apparent to one skilled in the art that varying substitutions and modifications may be made to the invention disclosed herein without departing from the scope and spirit of the invention. The invention illustratively described herein suitably may be practiced in the absence of any element or elements, or limitation or limitations, which is not specifically disclosed herein as essential. Thus, for example, in each instance herein, in embodiments or examples of the present invention, any of the terms “comprising”, “including”, containing”, etc. are to be read expansively and without limitation. The methods and processes illustratively described herein suitably may be practiced in differing orders of steps, and that they are not necessarily restricted to the orders of steps indicated herein or in the claims. It is also noted that as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural reference, and the plural include singular forms, unless the context clearly dictates otherwise. Under no circumstances may the patent be interpreted to be limited to the specific examples or embodiments or methods specifically disclosed herein. Under no circumstances may the patent be interpreted to be limited by any statement made by any Examiner or any other official or employee of the Patent and Trademark Office unless such statement is specifically and without qualification or reservation expressly adopted in a responsive writing by Applicants.
The invention has been described broadly and generically herein. Each of the narrower species and subgeneric groupings falling within the generic disclosure also form part of the invention. The terms and expressions that have been employed are used as terms of description and not of limitation, and there is no intent in the use of such terms and expressions to exclude any equivalent of the features shown and described or portions thereof, but it is recognized that various modifications are possible within the scope of the invention as claimed. Thus, it will be understood that although the present invention has been specifically disclosed by preferred embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to by those skilled in the art, and that such modifications and variations are considered to be within the scope of this invention as defined by the appended claims.
This invention was made with governmental support under Grant Numbers 1R43DA041966-01; and 1R43DA043325-01, both awarded by the National Institute on Drug Abuse. The government has certain rights in the invention.
Number | Name | Date | Kind |
---|---|---|---|
20090325274 | Hamada | Dec 2009 | A1 |
20130209334 | Wilson | Aug 2013 | A1 |
Number | Date | Country | |
---|---|---|---|
20180113126 A1 | Apr 2018 | US |
Number | Date | Country | |
---|---|---|---|
62412734 | Oct 2016 | US |